ImmunoPrecise Antibodies IPA Stock
ImmunoPrecise Antibodies Price Chart
ImmunoPrecise Antibodies IPA Financial and Trading Overview
| ImmunoPrecise Antibodies stock price | 0.46 USD |
| Previous Close | 2.85 USD |
| Open | 2.88 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 3000 |
| Day's Range | 2.82 - 2.94 USD |
| 52 Week Range | 2.35 - 6.5 USD |
| Volume | 39.69K USD |
| Avg. Volume | 91.56K USD |
| Market Cap | 72.06M USD |
| Beta (5Y Monthly) | 0.536971 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.21 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.04 USD |
IPA Valuation Measures
| Enterprise Value | 67.22M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.1607146 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.5528922 |
| Price/Book (mrq) | 1.181038 |
| Enterprise Value/Revenue | 3.314 |
| Enterprise Value/EBITDA | -2.774 |
Trading Information
ImmunoPrecise Antibodies Stock Price History
| Beta (5Y Monthly) | 0.536971 |
| 52-Week Change | -35.056% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.5 USD |
| 52 Week Low | 2.35 USD |
| 50-Day Moving Average | 2.89 USD |
| 200-Day Moving Average | 4.18 USD |
IPA Share Statistics
| Avg. Volume (3 month) | 91.56K USD |
| Avg. Daily Volume (10-Days) | 39.29K USD |
| Shares Outstanding | 24.94M |
| Float | 20.85M |
| Short Ratio | 0.56 |
| % Held by Insiders | 1.55% |
| % Held by Institutions | 5.72% |
| Shares Short | 98.17K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.38% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | April 30, 2023 |
Profitability
| Profit Margin | -128.55% |
| Operating Margin (ttm) | -129.41% |
| Gross Margin | 55.85% |
| EBITDA Margin | -119.47% |
Management Effectiveness
| Return on Assets (ttm) | -23.62% |
| Return on Equity (ttm) | -47.94% |
Income Statement
| Revenue (ttm) | 20.28M USD |
| Revenue Per Share (ttm) | 0.85 USD |
| Quarterly Revenue Growth (yoy) | 7.39% |
| Gross Profit (ttm) | 10.77M USD |
| EBITDA | -24233000 USD |
| Net Income Avi to Common (ttm) | -26075000 USD |
| Diluted EPS (ttm) | -0.74 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.32M USD |
| Total Cash Per Share (mrq) | 0.45 USD |
| Total Debt (mrq) | 7.48M USD |
| Total Debt/Equity (mrq) | 12.24 USD |
| Current Ratio (mrq) | 2.837 |
| Book Value Per Share (mrq) | 2.447 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19386000 USD |
| Levered Free Cash Flow (ttm) | -9563375 USD |
Profile of ImmunoPrecise Antibodies
| Country | United States |
| State | BC |
| City | Victoria |
| Address | 3204–4464 Markham Street |
| ZIP | V8Z 7X8 |
| Phone | N/A |
| Website | https://www.ipatherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 85 |
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.
Q&A For ImmunoPrecise Antibodies Stock
What is a current IPA stock price?
ImmunoPrecise Antibodies IPA stock price today per share is 0.46 USD.
How to purchase ImmunoPrecise Antibodies stock?
You can buy IPA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImmunoPrecise Antibodies?
The stock symbol or ticker of ImmunoPrecise Antibodies is IPA.
Which industry does the ImmunoPrecise Antibodies company belong to?
The ImmunoPrecise Antibodies industry is Biotechnology.
How many shares does ImmunoPrecise Antibodies have in circulation?
The max supply of ImmunoPrecise Antibodies shares is 47.18M.
What is ImmunoPrecise Antibodies Price to Earnings Ratio (PE Ratio)?
ImmunoPrecise Antibodies PE Ratio is now.
What was ImmunoPrecise Antibodies earnings per share over the trailing 12 months (TTM)?
ImmunoPrecise Antibodies EPS is -1.21 USD over the trailing 12 months.
Which sector does the ImmunoPrecise Antibodies company belong to?
The ImmunoPrecise Antibodies sector is Healthcare.
ImmunoPrecise Antibodies IPA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.51B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.51B USD — |
| NASDAQ Global Market Composite NQGM | 1854.61 USD — |
+0.81
|
— — | 1835.2 USD — | 1871.93 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}